Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Divestiture and Joint Venture Activities (Tables)

v3.21.2
Acquisitions, Divestiture and Joint Venture Activities (Tables)
9 Months Ended
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of recognized identified assets acquired and liabilities assumed The following table summarizes the preliminary amounts of the assets acquired and liabilities assumed at their acquisition dates, as well as their fair value at the acquisition dates and the noncontrolling interest acquired during the nine months ended September 30, 2021 (amounts in thousands):
Consideration
Cash $ 384,827 
Fair value of total consideration transferred
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash $ 1,352 
Patient accounts receivable 14,657 
Other receivables 205 
Prepaid expenses 387 
Other current assets 155 
Property and equipment 1,976 
Trade names 22,070 
Certificates of need/licenses 13,604 
Non-compete agreements 1,821 
Operating lease right of use asset 7,933 
Other assets 84 
Accounts payable and other accrued liabilities (9,764)
Salaries, wages, and benefits payable (4,045)
Current operating lease liabilities (2,527)
Amounts due to government entities (102)
Deferred employer payroll tax (1,692)
Long-term operating lease liabilities (5,407)
Total identifiable assets and liabilities $ 40,707 
Noncontrolling interest $ 113 
Goodwill, including noncontrolling interest of $78
$ 344,233